Guanjun Dong

Discovery of Potent and Selective 2-(Benzylthio)pyrimidine-based DCN1-UBC12 Inhibitors for Anticardiac Fibrotic Effects.

Wen-en Zhao, Xinhui Zhang, Liying Ma, 2021, Journal of medicinal chemistry.

Development of phenyltriazole thiol-based derivatives as highly potent inhibitors of DCN1-UBC12 interaction.

Wen-en Zhao, Lina Ding, Wenjuan Zhou, 2021, European journal of medicinal chemistry.

Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma.

Ting Yu, G. Gao, Guanjun Dong, 2022, Journal of medicinal chemistry.

Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer

Guanjun Dong, Guan-Jun Dong, Jia-Le Xu, 2022, International journal of molecular sciences.

Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing hydrazone fragment as potent and selective anticancer agents.

Wen-en Zhao, Pengfei Jia, Wenjuan Zhou, 2020, Bioorganic chemistry.